Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows – operating activities:
Net loss	$ (11,829)	$ (2,242)	$ (5,053)
Non-cash items –
Share-based plans expense	407	690	725
Treasury shares issued for 401(k) contribution	1,601	1,515	1,215
Depreciation and amortization	1,836	1,861	1,979
Investment/asset impairment charges, net	112	46	112
Gain on dispositions, net	(46)	(2)	(6)
777X and 767 reach-forward losses	4,079
Other charges and credits, net	528	3	401
Changes in assets and liabilities –
Accounts receivable	(37)	(128)	142
Unbilled receivables	(60)	321	6
Advances and progress billings	4,069	3,365	108
Inventories	(12,353)	(1,681)	420
Other current assets	(16)	389	(591)
Accounts payable	(793)	1,672	838
Accrued liabilities	1,563	779	2,956
Income taxes receivable, payable and deferred	(567)	44	1,347
Other long-term liabilities	(329)	(313)	(158)
Pension and other postretirement plans	(959)	(1,049)	(1,378)
Financing receivables and operating lease equipment, net	512	571	142
Other	202	119	307
Net cash (used)/provided by operating activities	(12,080)	5,960	3,512
Cash flows – investing activities:
Payments to acquire property, plant and equipment	(2,230)	(1,527)	(1,222)
Proceeds from disposals of property, plant and equipment	49	27	35
Acquisitions, net of cash acquired	(50)	(70)
Proceeds from dispositions	124
Contributions to investments	(13,856)	(16,448)	(5,051)
Proceeds from investments	4,743	15,739	10,619
Supplier notes receivable	(694)	(162)
Repayments on supplier notes receivable	40
Purchase of distribution rights	(88)
Other	(11)	4	(11)
Net cash (used)/provided by investing activities	(11,973)	(2,437)	4,370
Cash flows – financing activities:
New borrowings	10,161	75	34
Debt repayments	(8,673)	(5,216)	(1,310)
Common stock issuance, net of issuance costs	18,200
Mandatory convertible preferred stock issuance, net of issuance costs	5,657
Stock options exercised		45	50
Employee taxes on certain share-based payment arrangements	(83)	(408)	(40)
Other	(53)	17
Net cash provided/(used) by financing activities	25,209	(5,487)	(1,266)
Effect of exchange rate changes on cash and cash equivalents	(47)	30	(73)
Net increase/(decrease) in cash & cash equivalents, including restricted	1,109	(1,934)	6,543
Cash & cash equivalents, including restricted, at beginning of year	12,713	14,647	8,104
Cash & cash equivalents, including restricted, at end of year	13,822	12,713	14,647
Less restricted cash & cash equivalents, included in Investments	21	22	33
Cash and cash equivalents at end of year	$ 13,801	$ 12,691	$ 14,614